Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections-Reference-Cited by-同舟云学术

Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections

Published:2019-02 Issue:2 Volume:357 Page:103-110
ISSN:0002-9629
Container-title:The American Journal of the Medical Sciences
language:en
Short-container-title:The American Journal of the Medical Sciences

Author:

Bonine Nicole Gidaya,Berger Ariel,Altincatal Arman,Wang Rosa,Bhagnani Tarun,Gillard Patrick,Lodise Thomas

Funder

Allergan

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. Available at: http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf; 2013. Accessed December 4, 2018

2. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection;Lodise;Antimicrob Agents Chemother,2007

3. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs;Sturkenboom;Br J Clin Pharmacol,2005

4. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain;Tellado;Scand J Infect Dis,2007

5. Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis;Raman;BMC Infect Dis,2015

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of single and multiple resistance mechanisms on bacterial response to meropenem;Clinical Microbiology and Infection;2024-10

2. Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2024-09-11

3. Outcomes of inadequate empiric therapy and timing of newer antibacterial therapy in hospitalized adults with culture-positive Enterobacterales and Pseudomonas aeruginosa: a multicenter analysis;BMC Infectious Diseases;2024-08-09

4. Rapid Raman spectroscopy-based test for antimicrobial resistance;2024-08-07

5. eHealth and mHealth in Antimicrobial Stewardship to Reduce Mortality in Empirical Antimicrobial Therapy and a Systematic Review with a Meta-Analysis of Adequate Therapy;Infectious Disease Reports;2024-08-01